Virex
- Product NDC
- 83027-0156
- 11-digit product format
- 830270156
- Labeler code
- 83027
- Product ID
- 83027-0156_9e93e78f-3a5f-4f26-95b1-5105c2b359ce
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Adenoviren Nosode, Asclepias Tuberosa, Calcarea Arsenicica, Camphora, Coxsackie A2 Nosode, Coxsackie A3 Nosode, Coxsackie A4 Nosode, Coxsackie A5 Nosode, Coxsackie A7 Nosode, Coxsackie B1 Nosode, Coxsackie B3 Nosode, Coxsackie B4 Nosode, Coxsackie B5 Nosode, Cytomegalovirus Nosode, Echinacea Purpurea, Epstein-Barr Virus Nosode, Euphrasia Officinalis, Influenzinum, Lac Vaccinum, Morbillinum, Natrum Muriaticum, Phytolacca Decandra, Thuja Occidentalis, Trifolium Pratense, Variolinum
- Dosage form
- SPRAY
- Route
- ORAL
- Labeler
- Nutritional Specialties, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2025-10-03
- Substance
- ASCLEPIAS TUBEROSA ROOT; CALCIUM ARSENATE; CAMPHOR (NATURAL); COW MILK; ECHINACEA PURPUREA WHOLE; EUPHRASIA STRICTA; HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN; HUMAN COXSACKIEVIRUS A; HUMAN COXSACKIEVIRUS A2; HUMAN COXSACKIEVIRUS A7; HUMAN COXSACKIEVIRUS B; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B3; HUMAN COXSACKIEVIRUS B5; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE; MEASLES VIRUS; PHYTOLACCA AMERICANA ROOT; SODIUM CHLORIDE; THUJA OCCIDENTALIS LEAFY TWIG; TRIFOLIUM PRATENSE FLOWER; VARIOLA VIRUS
- Active strength
- 3; 12; 12; 6; 3; 6; 15; 9; 9; 9; 18; 9; 9; 9; 15; 15; 12; 12; 12; 12; 16; 4; 4; 6; 3; 16 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
- Pharmacologic classes
- Actively Acquired Immunity [PE], Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Milk Proteins [CS], Non-Standardized Food Allergenic Extract [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Vaccines, Live, Unattenuated [Chemical/Ingredient]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Virex
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ASCLEPIAS TUBEROSA ROOT | 3 [hp_X]/mL |
| CALCIUM ARSENATE | 12 [hp_X]/mL |
| CAMPHOR (NATURAL) | 12 [hp_X]/mL |
| COW MILK | 6 [hp_X]/mL |
| ECHINACEA PURPUREA WHOLE | 3 [hp_X]/mL |
| EUPHRASIA STRICTA | 6 [hp_X]/mL |
| HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN | 15 [hp_C]/mL |
| HUMAN COXSACKIEVIRUS A | 9 [hp_C]/mL |
| HUMAN COXSACKIEVIRUS A2 | 9 [hp_C]/mL |
| HUMAN COXSACKIEVIRUS A7 | 9 [hp_C]/mL |
| HUMAN COXSACKIEVIRUS B | 18 [hp_C]/mL |
| HUMAN COXSACKIEVIRUS B1 | 9 [hp_C]/mL |
| HUMAN COXSACKIEVIRUS B3 | 9 [hp_C]/mL |
| HUMAN COXSACKIEVIRUS B5 | 9 [hp_C]/mL |
| HUMAN HERPESVIRUS 4 | 15 [hp_C]/mL |
| HUMAN HERPESVIRUS 5 | 15 [hp_X]/mL |
| INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) | 12 [hp_C]/mL |
| INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) | 12 [hp_C]/mL |
| INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE | 12 [hp_C]/mL |
| INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE | 12 [hp_C]/mL |
| MEASLES VIRUS | 16 [hp_X]/mL |
| PHYTOLACCA AMERICANA ROOT | 4 [hp_X]/mL |
| SODIUM CHLORIDE | 4 [hp_X]/mL |
| THUJA OCCIDENTALIS LEAFY TWIG | 6 [hp_X]/mL |
| TRIFOLIUM PRATENSE FLOWER | 3 [hp_X]/mL |
| VARIOLA VIRUS | 16 [hp_X]/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 1ZL82U5D18, 95OX15I8ZU, N20HL7Q941, 917J3173FT, QI7G114Y98, C9642I91WL, FKD3DUK39I, 6F61V9UVRC, 82KK5J435E, P3026TK92O, NCM5G1A67U, ADL68M27WD, 69O1DAO10G, 63E6RXM429, 2A26YW7PNX, 7COI029E6K, 6TU4EY6UNW, AU5C98U4BB, CYK5P89K8X, PS2DCE2WVF |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 83027-0156-1 | Virex | 60 mL in 1 BOTTLE, SPRAY | SPRAY | 60 | | 1 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 83027-0156-1 | 83027015601 | 60 mL in 1 BOTTLE, SPRAY (83027-0156-1) | 60 ml | 2025-10-03 | No | No | Current |